Search - tctmd.com

Displaying 41 - 60 of 66

Sort: Relevancy | Date

Presentation

Spontaneous MI After NSTE ACS Managed Without Revascularization

Presenter: Renato Lopes

March 15, 2016

Presentation

Does Stable NSTE-ACS Require Admission to Coronary Care Units?

Presenter: S. van Diepen

January 27, 2016

Presentation TCT 2015

NSTE-ACS Case Presentation: From Presentation Through Discharge

Presenter: Ajay J. Kirtane, Gary S. Mintz, Manish A. Parikh, Bo Xu, Qi Zhang

October 11, 2015

Presentation TCT 2015

NSTE-ACS: Risk Stratification and Treatment

Presenter: Emmanouil S. Brilakis, Dmitriy N. Feldman

October 11, 2015

Presentation

Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS

Presenter: Tobias Geisler

September 18, 2015

Presentation

RITA 3: 10-Year Mortality Outcome of Routine Invasive vs Selective Invasive Strategy in NSTE-ACS

Presenter: Robert A. Henderson

July 29, 2015

Presentation

Effect of an Invasive Strategy on Outcome in Patients ≥ 75 Years of Age With NSTE-ACS

Presenter: Gennaro Galasso

January 11, 2015

Presentation AHA 2014

Efficacy and safety of vorapaxar in NSTE ACS patients undergoing non-cardiac surgery

Presenter: S. van Diepen

November 16, 2014

Presentation

Reappraisal of Thienopyridine Pretreatmentin NSTE-ACS Patients

Presenter: A. Bellemain-Appaix

November 06, 2014

Presentation TCT 2014

Role of Intravascular Imaging in NSTE-ACS and STEMI

Presenter: Nils Johnson, Bernhard Witzenbichler, Michel R. Le May, Fernando Alfonso

September 16, 2014

Presentation TCT 2014

Role of FFR, IMR, and Other Physiologic Measures in NSTE-ACS and STEMI

Presenter: Nils Johnson, Bernhard Witzenbichler, Michel R. Le May, Colin Berry

September 16, 2014

Presentation TCT 2014

Preloading P2Y12 Antagonists in NSTE-ACS and STEMI: Safe and Effective? What Regimens?

Presenter: Dominick J. Angiolillo

September 13, 2014

Presentation TCT 2014

NSTE-ACS: Risk Stratification and Treatment

Presenter: Emmanouil S. Brilakis, Dmitriy N. Feldman

September 13, 2014

Presentation TCT 2014

Case #1: NSTE-ACS Caused by Neoatherosclerosis in Saphenous Bypass Grafts: Insights from OCT

Presenter: Dan Deleanu, Dariusz Dudek, Robert J. Gil, Greg L. Kaluza, Andrzej J. Ochala, Wojtek Wojakowski

September 13, 2014

Presentation

Impact of an Invasive Strategy on 5-Year Outcomes in Men and Women With NSTE-ACS

Presenter: Joakim Alfredsson

July 25, 2014

Presentation

SYNTAX Score and the Risk of Stent Thrombosis After PCI in Patients with NSTE-ACS

Presenter: M. Yadav

July 08, 2014

Presentation

Long-term Outcomes Associated with Hospital-Acquired Thrombocytopenia in Pts with NSTE-ACS

Presenter: Amit N. Vora

May 05, 2014

Presentation

Ticagrelor vs Clopidogrel in Patients with NSTE-ACS With or Without Revascularization

Presenter: D. Lindholm

April 25, 2014

Presentation

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Presenter: Sripal Bangalore

April 22, 2014

Presentation

Weekend vs. Weekday Presentation Does Not Affect NSTE ACS Patient Outcomes

Presenter: D. E. O?Neill

October 18, 2013

Advertisement

Spontaneous MI After NSTE ACS Managed Without Revascularization

Does Stable NSTE-ACS Require Admission to Coronary Care Units?

NSTE-ACS Case Presentation: From Presentation Through Discharge

NSTE-ACS: Risk Stratification and Treatment

Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS

RITA 3: 10-Year Mortality Outcome of Routine Invasive vs Selective Invasive Strategy in NSTE-ACS

Effect of an Invasive Strategy on Outcome in Patients ≥ 75 Years of Age With NSTE-ACS

Efficacy and safety of vorapaxar in NSTE ACS patients undergoing non-cardiac surgery

Reappraisal of Thienopyridine Pretreatmentin NSTE-ACS Patients

Role of Intravascular Imaging in NSTE-ACS and STEMI

Role of FFR, IMR, and Other Physiologic Measures in NSTE-ACS and STEMI

Preloading P2Y12 Antagonists in NSTE-ACS and STEMI: Safe and Effective? What Regimens?

NSTE-ACS: Risk Stratification and Treatment

Case #1: NSTE-ACS Caused by Neoatherosclerosis in Saphenous Bypass Grafts: Insights from OCT

Impact of an Invasive Strategy on 5-Year Outcomes in Men and Women With NSTE-ACS

SYNTAX Score and the Risk of Stent Thrombosis After PCI in Patients with NSTE-ACS

Long-term Outcomes Associated with Hospital-Acquired Thrombocytopenia in Pts with NSTE-ACS

Ticagrelor vs Clopidogrel in Patients with NSTE-ACS With or Without Revascularization

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Weekend vs. Weekday Presentation Does Not Affect NSTE ACS Patient Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content